Boston Healthcare to expand pricing, economics and reimbursement consulting svcs

By Admin
Boston Healthcare is expanding its health economics, pricing, and reimbursement consulting services with the forming of the advisory practice in Asia...

Boston Healthcare is expanding its health economics, pricing, and reimbursement consulting services with the forming of the advisory practice in Asia.

This enhanced presence in Asia Pacific region enables Boston Healthcare to continue to effectively meet the reimbursement and market access needs of the pharmaceutical, medical device and diagnostic companies globally.

The Asia practice will be headed by Betty Su, who will become the managing director for Boston Healthcare Associates International HongKong Limited, leading a team of consultants supporting clients in Hong Kong, China and other Asia-Pacific markets. Ms. Su has done his specialization in market access and regulatory strategy in China.

She also advises on drug, device and diagnostics companies on commercialization and business development opportunities. She also advises on biopharmaceutical, medical devices, imaging and diagnostic companies in areas of pricing, and reimbursement, sales and marketing, marketing development and growth strategy. 

Before her consulting role, Ms. Su held several positions at AstraZeneca in China in marketing, government affairs and corporate communications.  

Joseph V. Ferrara, President of Boston Healthcare said, “With our expanded presence in Asia, and the addition of Betty Su to our leadership team, Boston Healthcare continues to grow and enhance our strategic advisory to innovative companies around the globe.” Mr. Ferrara also said, “Hong Kong and China are rapidly growing pharmaceutical and medical device markets, as well as emerging leaders in health care technology innovation. The expansion of our practice in Asia provides our clients with strong support in reimbursement and market access in this vital region."

Share
Share

Featured Articles

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19